To further investigate the potential role of TROAP in glioma, we performed Kaplan‐Meier analysis of overall survival time (OS) in the TCGA glioma database and found that patients stratified by a media cutoff of TROAP level with lower TROAP expression had longer OS than those with higher levels of TROAP (Figure 2D). The gene discussed is TROAP; the disease is central nervous system cancer.